Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Charles Raison
Videos
The Impact of Psychedelics on the Brain
02/02/2022
Charles Raison, MD, discusses the history, pharmacology, and clinical potential of the lesser-known psychedelics, including Ibogain, 5-MeO-DMT, LSD, and DMT.
Charles Raison, MD, discusses the history, pharmacology, and clinical potential of the lesser-known psychedelics, including Ibogain, 5-MeO-DMT, LSD, and DMT.
Charles Raison, MD, discusses...
02/02/2022
Psych Congress Network
Raison and Penn
Videos
The History of Psychedelics
02/02/2022
Psych Congress Steering Committee Members, Charles Raison, MD, and Andrew Penn, MS, PMHNP, discuss a history of psychedelics, including indigenous origins of psychedelic use, key events in traditional and contemporary uses, and the historical...
Psych Congress Steering Committee Members, Charles Raison, MD, and Andrew Penn, MS, PMHNP, discuss a history of psychedelics, including indigenous origins of psychedelic use, key events in traditional and contemporary uses, and the historical...
Psych Congress Steering...
02/02/2022
Psych Congress Network

Advertisement

Rakesh Jain
Videos
Is There A New Approach to Antipsychotic-Related Weight Gain? A Brief Journal Club With Rakesh Jain, MD
02/02/2022
In this installment, Rakesh Jain, MD, MPH, reviews an article from The Lancet Psychiatry.
In this installment, Rakesh Jain, MD, MPH, reviews an article from The Lancet Psychiatry.
In this installment, Rakesh...
02/02/2022
Psych Congress Network
Samantha Lau
Videos
Unpacking Women’s Mental Health Care and Trauma-Informed Psychotherapy
02/01/2022
Samantha Lau, MSN, FNP-BC, PMHNP-BC, discusses trauma-informed psychotherapy and how it “impacts someone's mental health, physical health, and relationships.”
Samantha Lau, MSN, FNP-BC, PMHNP-BC, discusses trauma-informed psychotherapy and how it “impacts someone's mental health, physical health, and relationships.”
Samantha Lau, MSN, FNP-BC,...
02/01/2022
Psych Congress Network
IV ketamine
Videos
The Biomedical Model vs Psychedelic Model in IV Ketamine Treatment
02/01/2022
Ben Medrano, MD, and Michael J Verbora, MD, MBA, discuss the pros and cons of the biomedical model and the psychedelic model in IV ketamine treatment and the KAP approach.
Ben Medrano, MD, and Michael J Verbora, MD, MBA, discuss the pros and cons of the biomedical model and the psychedelic model in IV ketamine treatment and the KAP approach.
Ben Medrano, MD, and Michael J...
02/01/2022
Psych Congress Network

Advertisement

Saundra Jain
Videos
Psychedelics Use Outside of the Clinical Setting
01/14/2022
Saundra Jain, MA, PsyD, LPC, discusses the use of psychedelic-assisted therapies outside of the clinical setting.
Saundra Jain, MA, PsyD, LPC, discusses the use of psychedelic-assisted therapies outside of the clinical setting.
Saundra Jain, MA, PsyD, LPC,...
01/14/2022
Psych Congress Network
Kwasi Aduesi
Videos
Treatment Equity and Ease of Access to Psychedelic-Assisted Therapy
01/13/2022
Kwasi Adusei, DNP, PMHNP, discusses equity in psychedelic medicine, the current climate regarding access to psychedelic medicine, and impact on public health.
Kwasi Adusei, DNP, PMHNP, discusses equity in psychedelic medicine, the current climate regarding access to psychedelic medicine, and impact on public health.
Kwasi Adusei, DNP, PMHNP,...
01/13/2022
Psych Congress Network
Edward Kaftarian
Videos
Telepsychiatry Reduces Barriers and Increases Mental Health Care Access
01/10/2022
Edward Kaftarian, MD, discusses the impact telepsychiatry has had on access to mental healthcare, including removing barriers, and whether or not specific mental health disorders are contraindicated with the medium.
Edward Kaftarian, MD, discusses the impact telepsychiatry has had on access to mental healthcare, including removing barriers, and whether or not specific mental health disorders are contraindicated with the medium.
Edward Kaftarian, MD, discusses...
01/10/2022
Psych Congress Network

Advertisement

rakesh jain
Videos
Rakesh Reviews: Predictors of Diagnostic Transition From Major Depressive Disorder to Bipolar Disorder: A Retrospective Observational Network Study
01/10/2022
Introducing the new journal club hosted by Rakesh Jain, MD, MPH. During this review, Dr Jain reviews an article from Translational Psychiatry.
Introducing the new journal club hosted by Rakesh Jain, MD, MPH. During this review, Dr Jain reviews an article from Translational Psychiatry.
Introducing the new journal club...
01/10/2022
Psych Congress Network
Dr King
Videos
Screening for Suicidal Ideation in the Emergency Department
01/07/2022
Cheryl King, PhD, discusses the importance of developing the CASSY suicide screening tool for youth in emergency departments.
Cheryl King, PhD, discusses the importance of developing the CASSY suicide screening tool for youth in emergency departments.
Cheryl King, PhD, discusses the...
01/07/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Popular Now

Videos
AIMS Exam Instructional Video
01/05/2018
Psych Congress co-chair Rakesh Jain, MD, MPH, explains the importance of the Abnormal Involuntary Movement Scale (AIMS) exam in the diagnosis and monitoring of patients with tardive dyskinesia.
Psych Congress co-chair Rakesh Jain, MD, MPH, explains the importance of the Abnormal Involuntary Movement Scale (AIMS) exam in the diagnosis and monitoring of patients with tardive dyskinesia.
Psych Congress co-chair Rakesh...
01/05/2018
Psychiatry & Behavioral Health
FDA approval featuring craig chepke
News
FDA Approves First Schizophrenia Treatment in Over 3 Decades
09/27/2024
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.
The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.
The US Food and Drug...
09/27/2024
Psych Congress Network
BHE Podcast
BHE Podcast
BHE Podcast, Episode 029 – Lisa Richardson, Beyond Healthcare CEO
07/29/2022
Lisa Richardson, CEO and co-founder of Beyond Healthcare, discusses the importance of connection and community, both in caring for clients and their families, as well as for building a healthy workplace for staff.
Lisa Richardson, CEO and co-founder of Beyond Healthcare, discusses the importance of connection and community, both in caring for clients and their families, as well as for building a healthy workplace for staff.
Lisa Richardson, CEO and...
07/29/2022
Behavioral Healthcare Executive
TD MOA
Anticholinergics and VMAT-2 Inhibitors: Different MOAs, Different Results
05/09/2022
This video shows the importance of understanding the mechanism of action that is associated with better treating tardive dyskinesia.
This video shows the importance of understanding the mechanism of action that is associated with better treating tardive dyskinesia.
This video shows the importance...
05/09/2022
Psychiatry & Behavioral Health
goldberg
Podcasts
The Link Between Lithium Use and Tardive Dyskinesia
12/29/2021
Dr Joseph Goldberg provides information on how lithium use for bipolar disorder can cause tardive dyskinesia and how to correctly identify and address this problem.
Dr Joseph Goldberg provides information on how lithium use for bipolar disorder can cause tardive dyskinesia and how to correctly identify and address this problem.
Dr Joseph Goldberg provides...
12/29/2021
Psych Congress Network

Advertisement

Advertisement

Advertisement

Sign Up

Psychiatry & Behavioral Health Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use